ENTITY
Gilead Sciences

Gilead Sciences (GILD US)

149
Analysis
Health Care • United States
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
more
•26 Jun 2016 11:49

The Dark Side of Glocalization (Even if Investment Opportunities)

Last week in my notes I pointed to the investment world being upside down and there being too much risk to be fully invested.Let’s set aside...

Share
•24 Jun 2016 16:11

Will Brexit Break EM's Back?

Against market expectations the British have voted to exit the European Union, a process that could take a few years.Ā The first order impact is...

Logo
317 Views
Share
•10 Jun 2016 16:42

Generation Hashtag as an Investment Theme

Forget everything you learned about Millennials....Millennials were ā€˜digital’ as defined by the discrete electronic tasks they performed on...

Logo
300 Views
Share
•26 May 2016 21:55

Internet of Things in Agriculture

A few months ago, I wrote a piece titled "Investing in the Internet of Things" and I made a case for the bright future of IoT and its myriad...

Logo
541 Views
Share
•09 May 2016 09:47

Morningstar Markets Observer: Q2 2016

All fixed-income indexes posted especially strong returns considering the current low-yield environment, because of falling interest rates and...

Share
x